NCT01180621 - Evaluation of Seasonal Influenza Vaccine for 2010-2011 in Young Children | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

April 30, 2011

Conditions

Seasonal Influenza

Interventions

BIOLOGICAL

Fluviral

0.25 mL Fluviral for children up to and including 35 months of age 0.50 mL Fluviral for children 36-59 months of age

Trial Locations (4)

ACHIEVE Research, Alberta Children's Hospital, Calgary

Vaccine Evaluation Center, Vancouver

Candian Center for Vaccinology, Dalhousie University, Halifax

McGill University Health Centre - Vaccine Study Centre, Montreal